Two landmark trials give CVD outcomes for diabetes drugs
Results for linagliptin and dapagliflozin
14th November 2018
By Clare Pain
Two trials looking at cardiovascular and renal outcomes in patients on therapy for type 2 diabetes will help doctors tailor treatment better to the patient, a diabetes specialist says.